WASHINGTON — Taking action in the wake of massive product recalls, the Food and Drug Administration has initiated the filing of a consent decree of permanent injunction against McNeil-PPC and two of its officers for failing to comply with federal good manufacturing practice requirements. The FDA said Thursday that the action prevents McNeil, a Johnson & Johnson subsidiary, from manufacturing and distributing drugs from its Fort Washington, Pa., facility until the agency determines that its operations are compliant with the law. McNeil announced Thursday that the company has finalized the terms of the consent decree with the FDA for manufacturing facilities operated by its McNeil Consumer Healthcare Division in Las Piedras, Puerto Rico, and in Fort Washington and Lancaster, Pa. The company noted that the decree is subject to approval by the U.S. District Court for the Eastern District of Pennsylvania.